Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

8.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PROducing More Evidence to Reduce Glucocorticoids in Systemic Lupus Erythematosus: Putting Patient-Reported Outcomes in the Picture.

The Journal of rheumatology·2026
Same author

Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026
Same author

Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial data.

Lupus science & medicine·2026
Same author

How changes in salinity modify patterns of gastrointestinal motility in the intestine of freshwater barramundi.

Autonomic neuroscience : basic & clinical·2026
Same author

Assessing the Tautomerase Activity of MIF Using L-Dopachrome.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Using Luciferase Reporter Cells to Assess the Effects of MIF Inhibitors on NF-κB Activation.

Methods in molecular biology (Clifton, N.J.)·2026

Related Experiment Video

Updated: Sep 5, 2025

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
11:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

12.0K

GILZ regulates type I interferon release and sequesters STAT1.

Champa Nataraja1, Jacqueline Flynn1, Wendy Dankers1

  • 1Rheumatology Research Group, Monash University Centre for Inflammatory Disease, School of Clinical Sciences at Monash Health, 246 Clayton Rd, Clayton, 3168, Melbourne, Australia.

Journal of Autoimmunity
|July 10, 2022
PubMed
Summary
This summary is machine-generated.

Glucocorticoid-induced leucine zipper (GILZ) gene restoration may offer a safer alternative to current treatments by regulating type I interferon responses. This approach could reduce reliance on glucocorticoids and their adverse effects.

Keywords:
AutoimmunityGILZGlucocorticoidsInterferonSTAT1Systemic lupus erythematosus

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.5K
Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

10.1K

Related Experiment Videos

Last Updated: Sep 5, 2025

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
11:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

12.0K
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.5K
Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

10.1K

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Glucocorticoids are essential for immune suppression but cause severe side effects.
  • Developing safer alternatives is crucial for managing inflammatory and autoimmune diseases.
  • Reduced Glucocorticoid-induced leucine zipper (GILZ) is linked to increased inflammation severity in diseases like SLE and Psoriasis.

Purpose of the Study:

  • To investigate the role of GILZ in regulating type I interferon (IFN) signaling.
  • To explore GILZ as a potential therapeutic target for reducing glucocorticoid dependence.

Main Methods:

  • Analysis of GILZ mRNA and protein levels in relation to inflammation.
  • Investigating the effect of GILZ overexpression on IFN-stimulated gene (ISG) expression.
  • Assessing GILZ's interaction with STAT1 and its impact on nuclear translocation.

Main Results:

  • Low GILZ levels permit type I IFN signature expression, which is amplified by TLR7 and TLR9 stimulation.
  • GILZ overexpression inhibits IFNα-induced ISG up-regulation.
  • GILZ directly binds STAT1, preventing its nuclear translocation and negatively regulating IFN-induced gene expression.

Conclusions:

  • GILZ plays a critical role in regulating both the expression and action of type I IFNs.
  • Restoring GILZ function presents a promising therapeutic strategy to mitigate type I IFN-driven inflammation and decrease reliance on glucocorticoids.